Oscar Health, Inc. (OSCR) EV/EBITDA Ratio: 259.51x
Is Oscar Health, Inc.’s EV/EBITDA ratio high or low?
Oscar Health, Inc.'s EV/EBITDA ratio of 259.51x is 94% above its 2-year average of 133.87x, around the middle of its 2-year range (10.95x–730.32x).
As of Sunday, June 21, 2026. 166.39% above its 12-month average of 97.42x.
OSCR EV/EBITDA Ratio Chart
OSCR Average EV/EBITDA Ratio Chart
OSCR Current vs Average EV/EBITDA Ratio Chart
OSCR EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
259.51x
EV/EBITDA RATIO AVG TTM
97.42x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+166.39%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
OSCR Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oscar Health, Inc. (OSCR) | $7.36B | 259.51x | 97.42x | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 18.06x | 12.03x | 61.41x | 32.91x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | 299.75x | 79.82x | 129.24x | 129.24x |
| Tempus AI, Inc. (TEM)vs › | $8.87B | N/A | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | 41.03x | 24.81x | 17.52x | 18.54x |
| Baxter International Inc. (BAX)vs › | $10.27B | 24.27x | 20.36x | 19.15x | 19.13x |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | N/A | 21.34x | 19.40x | 19.09x |
| Revvity, Inc. (RVTY)vs › | $11.16B | 17.70x | 17.09x | 19.85x | 18.23x |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 23.28x | 39.29x | 98.12x | 98.12x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | N/A | 45.04x | 33.13x | 30.20x |
EV/EBITDA vs. its own history
At 259.5, EV/EBITDA is richer than usual, sitting higher than 81% of its 2-year history.
2-year low
10.9
median
34.2
2-year high
730.3
Oscar Health, Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Oscar Health, Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Oscar Health, Inc. (OSCR)?
- The EV/EBITDA ratio for OSCR stock is 259.51x.
- Is Oscar Health, Inc.'s EV/EBITDA ratio high or low?
- Oscar Health, Inc.'s EV/EBITDA ratio of 259.51x is 94% above its 2-year average of 133.87x, around the middle of its 2-year range (10.95x–730.32x).
- What is the TTM average EV/EBITDA ratio for Oscar Health, Inc. (OSCR)?
- The TTM average EV/EBITDA ratio for OSCR stock is 97.42x.
Oscar Health, Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-18 | 259.51x |
| 2026-06-17 | 257.28x |
| 2026-06-16 | 262.25x |
| 2026-06-15 | 272.20x |
| 2026-06-12 | 257.11x |
| 2026-06-11 | 268.26x |
| 2026-06-10 | 250.08x |
| 2026-06-09 | 239.28x |
| 2026-06-08 | 242.19x |
| 2026-06-05 | 192.81x |
| 2026-06-04 | 177.21x |
| 2026-06-03 | 124.05x |
| 2026-06-02 | 135.03x |
| 2026-06-01 | 166.40x |
| 2026-05-29 | 153.72x |
| 2026-05-28 | 155.43x |
| 2026-05-27 | 149.60x |
| 2026-05-26 | 147.89x |
| 2026-05-22 | 160.75x |
| 2026-05-21 | 152.17x |
| 2026-05-20 | 174.12x |
| 2026-05-19 | 192.98x |
| 2026-05-18 | 206.36x |
| 2026-05-15 | 172.41x |
| 2026-05-14 | 169.49x |
| 2026-05-13 | 177.55x |
| 2026-05-12 | 179.44x |
| 2026-05-11 | 149.77x |
| 2026-05-08 | 137.94x |
| 2026-05-07 | 130.40x |
| 2025-08-06 | 12.37x |
| 2025-08-05 | 11.57x |
| 2025-08-04 | 11.60x |
| 2025-08-01 | 11.20x |
| 2025-07-31 | 11.92x |
| 2025-07-30 | 11.85x |
| 2025-07-29 | 11.60x |
| 2025-07-28 | 12.88x |
| 2025-07-25 | 12.54x |
| 2025-07-24 | 12.16x |
| 2025-07-23 | 14.74x |
| 2025-07-22 | 12.93x |
| 2025-07-21 | 11.26x |
| 2025-07-18 | 10.95x |
| 2025-07-17 | 11.65x |
| 2025-07-16 | 13.93x |
| 2025-07-15 | 13.27x |
| 2025-07-14 | 13.52x |
| 2025-07-11 | 12.43x |
| 2025-07-10 | 14.21x |
| 2025-07-09 | 15.06x |
| 2025-07-08 | 15.79x |
| 2025-07-07 | 16.19x |
| 2025-07-03 | 15.66x |
| 2025-07-02 | 15.89x |
| 2025-07-01 | 21.81x |
| 2025-06-30 | 23.34x |
| 2025-06-27 | 21.75x |
| 2025-06-26 | 21.86x |
| 2025-06-25 | 19.86x |
| 2025-06-24 | 21.15x |
| 2025-06-23 | 21.76x |
| 2025-06-20 | 23.00x |
| 2025-06-18 | 19.22x |
| 2025-06-17 | 15.11x |
| 2025-06-16 | 13.31x |
| 2025-06-13 | 11.77x |
| 2025-06-12 | 12.37x |
| 2025-06-11 | 12.08x |
| 2025-06-10 | 12.91x |
| 2025-06-09 | 13.02x |
| 2025-06-06 | 14.04x |
| 2025-06-05 | 14.40x |
| 2025-06-04 | 12.08x |
| 2025-06-03 | 12.23x |
| 2025-06-02 | 12.25x |
| 2025-05-30 | 11.54x |
| 2025-05-29 | 11.54x |
| 2025-05-28 | 11.68x |
| 2025-05-27 | 13.41x |
| 2025-05-23 | 12.11x |
| 2025-05-22 | 12.42x |
| 2025-05-21 | 13.18x |
| 2025-05-20 | 15.66x |
| 2025-05-19 | 16.10x |
| 2025-05-16 | 17.28x |
| 2025-05-15 | 15.80x |
| 2025-05-14 | 15.77x |
| 2025-05-13 | 16.36x |
| 2025-05-12 | 16.20x |
| 2025-05-09 | 16.65x |
| 2025-05-08 | 16.57x |
| 2025-05-07 | 16.51x |
| 2025-05-06 | 25.16x |
| 2025-05-05 | 24.95x |
| 2025-05-02 | 25.55x |
| 2025-05-01 | 25.10x |
| 2025-04-30 | 24.98x |
| 2025-04-29 | 25.40x |
| 2025-04-28 | 23.82x |
| 2025-04-25 | 22.66x |
| 2025-04-24 | 22.07x |
| 2025-04-23 | 22.01x |
| 2025-04-22 | 20.79x |
| 2025-04-21 | 20.90x |
| 2025-04-17 | 22.07x |
| 2025-04-16 | 23.02x |
| 2025-04-15 | 23.32x |
| 2025-04-14 | 23.23x |
| 2025-04-11 | 23.67x |
| 2025-04-10 | 22.72x |
| 2025-04-09 | 23.52x |
| 2025-04-08 | 21.14x |
| 2025-04-07 | 23.58x |
| 2025-04-04 | 24.95x |
| 2025-04-03 | 26.77x |
| 2025-04-02 | 26.05x |
| 2025-04-01 | 24.86x |
| 2025-03-31 | 25.28x |
| 2025-03-28 | 25.85x |
| 2025-03-27 | 26.38x |
| 2025-03-26 | 27.22x |
| 2025-03-25 | 28.50x |
| 2025-03-24 | 27.81x |
| 2025-03-21 | 25.07x |
| 2025-03-20 | 24.72x |
| 2025-03-19 | 24.51x |
| 2025-03-18 | 24.45x |
| 2025-03-17 | 26.29x |
| 2025-03-14 | 25.61x |
| 2025-03-13 | 24.60x |
| 2025-03-12 | 28.50x |
| 2025-03-11 | 29.87x |
| 2025-03-10 | 32.48x |
| 2025-03-07 | 33.76x |
| 2025-03-06 | 32.75x |
| 2025-03-05 | 34.63x |
| 2025-03-04 | 32.13x |
| 2025-03-03 | 31.18x |
| 2025-02-28 | 29.75x |
| 2025-02-27 | 30.28x |
| 2025-02-26 | 32.90x |
| 2025-02-25 | 32.72x |
| 2025-02-24 | 31.71x |
| 2025-02-21 | 30.37x |
| 2025-02-20 | 34.09x |
| 2025-02-19 | 32.73x |
| 2025-02-18 | 32.36x |
| 2025-02-14 | 25.98x |
| 2025-02-13 | 24.91x |
| 2025-02-12 | 26.78x |
| 2025-02-11 | 27.71x |
| 2025-02-10 | 29.34x |
| 2025-02-07 | 29.29x |
| 2025-02-06 | 29.50x |
| 2025-02-05 | 32.09x |
| 2025-02-04 | 30.84x |
| 2025-02-03 | 34.76x |
| 2025-01-31 | 34.36x |
| 2025-01-30 | 36.23x |
| 2025-01-29 | 34.58x |
| 2025-01-28 | 33.51x |
| 2025-01-27 | 33.56x |
| 2025-01-24 | 34.50x |
| 2025-01-23 | 34.02x |
| 2025-01-22 | 33.46x |
| 2025-01-21 | 31.83x |
| 2025-01-17 | 32.49x |
| 2025-01-16 | 29.96x |
| 2025-01-15 | 31.11x |
| 2025-01-14 | 29.90x |
| 2025-01-13 | 27.88x |
| 2025-01-10 | 27.90x |
| 2025-01-08 | 30.87x |
| 2025-01-07 | 28.46x |
| 2025-01-06 | 29.34x |
| 2025-01-03 | 28.36x |
| 2025-01-02 | 26.22x |
| 2024-12-31 | 25.93x |
| 2024-12-30 | 26.30x |
| 2024-12-27 | 26.89x |
| 2024-12-26 | 27.93x |
| 2024-12-24 | 25.82x |
| 2024-12-23 | 26.35x |
| 2024-12-20 | 27.66x |
| 2024-12-19 | 26.09x |
| 2024-12-18 | 25.77x |
| 2024-12-17 | 26.09x |
| 2024-12-16 | 27.15x |
| 2024-12-13 | 26.51x |
| 2024-12-12 | 26.46x |
| 2024-12-11 | 28.38x |
| 2024-12-10 | 30.17x |
| 2024-12-09 | 34.23x |
| 2024-12-06 | 31.72x |
| 2024-12-05 | 33.83x |
| 2024-12-04 | 35.32x |
| 2024-12-03 | 38.07x |
| 2024-12-02 | 39.25x |
| 2024-11-29 | 36.31x |
| 2024-11-27 | 34.98x |
| 2024-11-26 | 33.51x |
| 2024-11-25 | 35.03x |
| 2024-11-22 | 32.71x |
| 2024-11-21 | 33.59x |
| 2024-11-20 | 35.43x |
| 2024-11-19 | 38.13x |
| 2024-11-18 | 32.71x |
| 2024-11-15 | 29.74x |
| 2024-11-14 | 31.27x |
| 2024-11-13 | 26.03x |
| 2024-11-12 | 26.25x |
| 2024-11-11 | 26.89x |
| 2024-11-08 | 26.19x |
| 2024-11-07 | 26.46x |
| 2024-11-06 | 34.22x |
| 2024-11-05 | 44.75x |
| 2024-11-04 | 43.80x |
| 2024-11-01 | 42.14x |
| 2024-10-31 | 38.94x |
| 2024-10-30 | 39.84x |
| 2024-10-29 | 35.66x |
| 2024-10-28 | 33.47x |
| 2024-10-25 | 36.64x |
| 2024-10-24 | 40.45x |
| 2024-10-23 | 35.69x |
| 2024-10-22 | 36.03x |
| 2024-10-21 | 35.81x |
| 2024-10-18 | 37.24x |
| 2024-10-17 | 38.94x |
| 2024-10-16 | 42.71x |
| 2024-10-15 | 41.09x |
| 2024-10-14 | 41.88x |
| 2024-10-11 | 43.46x |
| 2024-10-10 | 40.97x |
| 2024-10-09 | 44.14x |
| 2024-10-08 | 44.52x |
| 2024-10-07 | 45.28x |
| 2024-10-04 | 51.54x |
| 2024-10-03 | 47.95x |
| 2024-10-02 | 51.95x |
| 2024-10-01 | 53.39x |
| 2024-09-30 | 55.57x |
| 2024-09-27 | 54.74x |
| 2024-09-26 | 52.82x |
| 2024-09-25 | 56.97x |
| 2024-09-24 | 57.46x |
| 2024-09-23 | 59.80x |
| 2024-09-20 | 62.06x |
| 2024-09-19 | 63.34x |
| 2024-09-18 | 60.82x |
| 2024-09-17 | 58.29x |
| 2024-09-16 | 58.25x |
| 2024-09-13 | 57.08x |
| 2024-09-12 | 54.78x |
| 2024-09-11 | 53.54x |
| 2024-09-10 | 41.28x |
| 2024-09-09 | 41.47x |
| 2024-09-06 | 39.65x |
| 2024-09-05 | 41.20x |
Showing the most recent 260 of 343 data points. The chart above shows the full history.
Related Metrics
About Oscar Health, Inc.
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Mark Thomas Bertolini